3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Encephalopathy, Hepatic

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Encephalopathy, Hepatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berding, G; Köstler, H; Weissenborn, K	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Encephalopathy, Hepatic

Article	Year
Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metabolic brain disease, 2000, Volume: 15, Issue:3 Topics: Aged; Benzamides; Biological Transport; Case-Control Studies; Contrast Media; Dopamine; Dopamine Antagonists; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Protein Binding; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	2000

Article

Year

Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy.

Metabolic brain disease, 2000, Volume: 15, Issue:3

Topics: Aged; Benzamides; Biological Transport; Case-Control Studies; Contrast Media; Dopamine; Dopamine Antagonists; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Protein Binding; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

2000